Merit Medical Systems INC Form 4 insider transactions

Director Stephen C. Evans sold 5,000 shares of Merit Medical Systems Inc. (MMSI) at an average price of $105.31 on March 3, 2025.

Neil Peterson, COO of Merit Medical Systems, reports acquisition and disposal of common stock and grants of restricted stock units.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems Inc., reports acquisition and disposal of company stock and stock options.

CEO Fred Lampropoulos reports acquisition and disposal of Merit Medical Systems (MMSI) stock, including exercises of stock options and surrendering shares for tax obligations.

Voigt Michel James, Chief Human Resources Officer of Merit Medical Systems, reports multiple transactions involving company stock, including acquisitions, disposals, and option exercises.

Raul Parra Jr., CFO and Treasurer of Merit Medical Systems, reports acquisition and disposal of company stock, including shares from performance stock units, tax surrender, restricted stock units, and open market sales.

Director Thomas James Gunderson of Merit Medical Systems reports the acquisition and disposal of company stock and derivative securities.

Director F. Ann Millner exercised stock options and sold shares of Merit Medical Systems Inc. on November 15, 2024, under a pre-arranged trading plan.

Raul Parra Jr., CFO and Treasurer of Merit Medical Systems, exercised stock options and sold shares on November 7, 2024.

Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options and sold shares on November 5, 2024.

CFO of Merit Medical Systems, Raul Parra Jr., exercised stock options and sold shares on November 5, 2024.

Director F. Ann Millner of Merit Medical Systems exercised stock options and sold shares on June 28, 2024, according to a Form 4 filing with the SEC.

Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options and sold 7,500 shares of common stock at an average price of $81.846 per share on June 10, 2024, according to a Form 4 filing with the SEC.

Director Michael McDonnell received 2,431 restricted stock units from Merit Medical Systems, vesting in May 2025.

Director Stephen C. Evans received 2,431 restricted stock units from Merit Medical Systems Inc. on May 16, 2024, which will vest on May 16, 2025, subject to continued service.

Director Lonny J Carpenter reports the acquisition of 2,431 restricted stock units in Merit Medical Systems, vesting on May 16, 2025.

Director Thomas James Gunderson received 2,431 restricted stock units from Merit Medical Systems, Inc.

Director David Floyd reports acquisition of 2,431 restricted stock units in Merit Medical Systems, Inc.

Director F. Ann Millner reports acquisition of 2,431 restricted stock units (RSUs) in Merit Medical Systems, Inc.

Silvia Perez, a director at Merit Medical Systems, received a grant of 2,431 restricted stock units (RSUs) on May 16, 2024, which will vest on May 16, 2025, subject to continued service.

Director Lynne Ward reported the acquisition of 2,431 restricted stock units (RSUs) in Merit Medical Systems, Inc.

Director Laura S. Kaiser received 2,431 restricted stock units from Merit Medical Systems, Inc. on May 16, 2024, which will vest on May 16, 2025, subject to continued service.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems Inc., reported a gift of 1,180 shares of common stock on March 14, 2024.

Raul Parra Jr., CFO and Treasurer of Merit Medical Systems, sold shares of the company's common stock on March 12, 2024.

Chief Commercial Officer Joseph Wright exercised stock options and sold 25,000 shares of Merit Medical Systems (MMSI) common stock on March 7, 2024.

Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options on March 6, 2024, acquiring 7,500 shares of common stock.

Voigt Michel James, Chief Human Resources Officer at Merit Medical Systems, reports transactions involving common stock and stock options, including acquisitions, disposals, and vesting of restricted stock units and performance stock units.

Neil Peterson, Chief Operating Officer of Merit Medical Systems, reports the acquisition of 7,319 restricted stock units (RSUs) on March 4, 2024.

Chief Commercial Officer Joseph Wright reports acquisition and disposal of Merit Medical Systems stock, including grants of restricted stock units and shares acquired from performance stock units.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems Inc., reports acquisition of restricted stock units and performance stock units, as well as shares surrendered for tax obligations.